Healthcare resources for inborn errors of immunity in the Asia-Pacific region
Motoi Yamashita(RIKEN Center for Integrative Medical Sciences), Hirokazu Kanegane(Tokyo Medical and Dental University), Jane C. Y. Wong(Queen Mary Hospital), Mahnaz Jamee(Jahrom University of Medical Sciences), Rajiva de Silva(Medical Research Institute), Peter McNaughton(Children's Health Queensland Hospital and Health Service), Satoshi Okada(Rockefeller University), Jaime S. Rosa Duque(Chinese University of Hong Kong), Intan Hakimah Ismail(Universiti Putra Malaysia), YL Lau(Chinese University of Hong Kong), Hsin‐Hui Yu(National Taiwan University), Dharmagat Bhattarai(Center for Molecular Dynamics - Nepal), Youjia Zhong, Dae Chul Jeong(Catholic University of Korea), Yunfei An(Sichuan University), Yae‐Jean Kim, Quang Van Vu(Hai Phong University of Management and Technology), Dina Muktiarti(University of Indonesia), Amit Rawat(Post Graduate Institute of Medical Education and Research), Lytheang Try, Vicky Wee Eng-Binas(De La Salle University – Dasmariñas), Monira Sarmin(International Centre for Diarrhoeal Disease Research), Suravat Homvises(Chulalongkorn University), Phub Tenzin(Centre for Bhutan Studies and GNH Research)
Cited by 1
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Gain-of-function human <i>STAT1</i> mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
|The Journal of Experimental Medicine|2011|797
Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells
|Blood|2005|495
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
|Journal of Allergy and Clinical Immunology|2017|318